BIO
Bio-Rad Laboratories
$316.41
+$1.95 (+0.62%)Jul 27, 2026
Key metrics
The numbers that frame BIO today
- Market cap
- $8.47B
- P/E (TTM)
- 50.2
- EV / FCF
- 26.1
- Gross margin
- 51.9%
- EV / Sales
- 3.6
- ROIC
- 2.9%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $236.73
- 52wk High
- $343.12
Growth
Revenue and earnings trend for BIO
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BIO
Is Bio-Rad Laboratories a good buy?
Hold. Bio-Rad Laboratories has mixed quality and mixed momentum. The setup is mixed. Growth looks poor. That could put pressure on the long-term business case. We think Bio-Rad Laboratories is selling at a fair price.
What is the market capitalization of BIO?
Bio-Rad Laboratories's market capitalization is $8.47B.
What is the P/E ratio for BIO stock?
Bio-Rad Laboratories's current P/E ratio is 50.2.
What is the 52-week high for BIO stock?
The 52-week high for Bio-Rad Laboratories is $343.12. The current close of $316.41 is 7.8% below that high.
What is the 52-week low for BIO stock?
The 52-week low for Bio-Rad Laboratories is $236.73. The current close of $316.41 is 33.7% above that low.
Does BIO stock pay dividends?
Bio-Rad Laboratories does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BIO?
Bio-Rad Laboratories's Debt / Equity ratio is 0.2.